Detalles de la búsqueda
1.
Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target.
BMC Pediatr
; 23(1): 119, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36922769
2.
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.
Emerg Infect Dis
; 28(6): 1233-1236, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470795
3.
Adherence to ready-to-use food and acceptability of outpatient nutritional therapy in HIV-infected undernourished Senegalese adolescents: research-based recommendations for routine care.
BMC Public Health
; 20(1): 695, 2020 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414346
4.
Improving the informed consent process among HIV-infected undisclosed minors participating in a biomedical research: insights from the multicentre nutritional SNACS study in Senegal.
Trop Med Int Health
; 24(3): 294-303, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30624827
5.
Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).
J Acquir Immune Defic Syndr
; 94(3): 262-272, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37851566
6.
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.
Open Forum Infect Dis
; 10(12): ofad582, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38156046
7.
Large Diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 After the Successive Epidemiological Waves, Including Omicron, in Guinea and Cameroon: Implications for Vaccine Strategies.
Open Forum Infect Dis
; 10(5): ofad216, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37152188
8.
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).
Pharmacoeconomics
; 39(3): 331-343, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355914
9.
Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO).
Pan Afr Med J
; 40: 124, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34909092
10.
Outcomes of the first meeting of the CAMEROON HIV RESEARCH FORUM (CAM-HERO).
Pan Afr Med J
; 40: 166, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970408
11.
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon.
Lancet HIV
; 7(10): e677-e687, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33010241
12.
Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study.
Food Nutr Bull
; 38(1): 27-36, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27881690
Resultados
1 -
12
de 12
1
Próxima >
>>